| 1 |
Koslover J, Bruce D, Patel S, Webb AJ. Metformin-'BRAINS & AIMS' pharmacological/prescribing principles of commonly prescribed (Top 100) drugs: Education and discussion. Br J Clin Pharmacol 2023;89:931-8. [PMID: 36575901 DOI: 10.1111/bcp.15653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Ying X, Rongjiong Z, Kahaer M, Chunhui J, Wulasihan M. Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease. Front Microbiol 2023;14:1088187. [PMID: 36778868 DOI: 10.3389/fmicb.2023.1088187] [Reference Citation Analysis]
|
| 3 |
Eriksson JW, Eliasson B, Bennet L, Sundström J. Registry-based randomised clinical trials: a remedy for evidence-based diabetes care? Diabetologia 2022;65:1575-86. [PMID: 35902386 DOI: 10.1007/s00125-022-05762-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Zainal AA, Merkhan MM. IMPACT OF ANTIDIABETIC DRUGS ON RISK AND OUTCOME OF COVID-19 INFECTION: A REVIEW. Mil Med Sci Lett 2022;91:140-160. [DOI: 10.31482/mmsl.2022.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Cui F, He X. IGF-1 ameliorates streptozotocin-induced pancreatic β cell dysfunction and apoptosis via activating IRS1/PI3K/Akt/FOXO1 pathway. Inflamm Res 2022. [PMID: 35333936 DOI: 10.1007/s00011-022-01557-3] [Reference Citation Analysis]
|
| 6 |
Gouda P, Zheng S, Peters T, Fudim M, Randhawa VK, Ezekowitz J, Mavrakanas TA, Giannetti N, Tsoukas M, Lopes R, Sharma A. Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies. Curr Heart Fail Rep 2021;18:253-63. [PMID: 34427881 DOI: 10.1007/s11897-021-00527-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Hamann A. Update Typ-2-Diabetes. Diabetologe 2021;17:501-15. [DOI: 10.1007/s11428-021-00783-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Lazarus G, Suhardi IP, Wiyarta E, Rasyidah RA, Barliana JD. Is there a need to reconsider the use of metformin in COVID-19 patients with type 2 diabetes mellitus? Int J Diabetes Dev Ctries 2021;41:377-82. [PMID: 33679040 DOI: 10.1007/s13410-021-00924-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Lee M, Ovbiagele B. Blood glucose, antidiabetic drugs, and risk of stroke. Precis Future Med 2021;5:13-20. [DOI: 10.23838/pfm.2020.00156] [Reference Citation Analysis]
|
| 10 |
Gupta A. How does metformin compare with other antidiabetes medications as monotherapy in adults with type 2 diabetes mellitus? Cochrane Clinical Answers 2020. [DOI: 10.1002/cca.3257] [Reference Citation Analysis]
|
